Effect of Sitagliptin on Adiponectin and oxidative stress in Diabetic Patients - Japan (START-J study)

Effect of Sitagliptin on Adiponectin and oxidative stress in Diabetic Patients - Japan (START-J study) - Effect of Sitagliptin on Adiponectin

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004721

Enrollment

100

Registered

2011-01-01

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetic patients

Interventions

Control (Conventionally normal treatment) Sitagliptin treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient with type 2 diabetes mellitus

Exclusion criteria

Exclusion criteria: 1) The patient who takes insulin treatment 2) The patient who takes treatment with thiazolidinediones 3) The patient with severe renal function disorder 4) The patient who takes sulfonylurea medicine more than the following amount Glimepiride 2mg, Glibenclamide 1.25mg, Gliclazide 40mg

Design outcomes

Primary

Measure	Time frame
HbA1c, adiponectin	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026